Company GSK plc

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:00 2025-07-18 EDT			5-day change	1st Jan Change
1,348.00 ^GBX	-4.60%		-4.30%	+0.11%

07-18	US FDA advisers recommend against Otsuka's PTSD combination treatment	RE
07-18	Health Care Declines as Traders Hedge on Growth Views - Health Care Roundup	DJ

Business description: GSK plc

GSK plc is a global biopharma company. The Companyâs segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

Number of employees: 68,629

Sales by Activity: GSK plc

Fiscal Period: December	2020	2021	2022	2023	2024
Commercial Operations	-	-	29.32B	30.33B	31.38B
Corporate and Other Unallocated Turnover	28M	-	-	-	-
Consumer Healthcare	10.03B	9.61B	-	-	-
Vaccines	6.98B	6.78B	-	-	-
Pharmaceuticals	17.06B	17.73B	-	-	-

See all business segments

Geographical breakdown of sales: GSK plc

Fiscal Period: December	2020	2021	2022	2023	2024
United States (US)	14.56B	15.09B	14.54B	15.82B	16.38B
International	18.56B	18.05B	14.09B	13.82B	14.28B
United Kingdom (UK)	980M	975M	695M	693M	708M

See all geographic segments

Executive Committee: GSK plc

Manager	Title	Age	Since
Emma Walmsley CEO	Chief Executive Officer	56	2017-03-31
Julie Brown DFI	Director of Finance/CFO	63	2023-04-30
James Ford CMP	Compliance Officer	-	2018-07-31
Shobie Ramakrishnan CTO	Chief Tech/Sci/R&D Officer	-	2021-11-30
Tony Wood CTO	Chief Tech/Sci/R&D Officer	-	2022-01-18

See GSK PLC governance

Composition of the Board of Directors: GSK plc

Director	Title	Age	Since
Emma Walmsley BRD	Director/Board Member	56	2016-12-31
Hal Barron BRD	Director/Board Member	63	2017-12-31
Jonathan Symonds CHM	Chairman	67	2019-08-31
Charles Bancroft BRD	Director/Board Member	65	2020-04-30
Anne Beal BRD	Director/Board Member	63	2021-05-05
Harry Dietz BRD	Director/Board Member	67	2021-12-31
Vishal Sikka BRD	Director/Board Member	58	2022-07-17
Elizabeth Anderson BRD	Director/Board Member	67	2022-08-31
Julie Brown BRD	Director/Board Member	63	2023-04-30
Wendy Becker BRD	Director/Board Member	59	2023-09-30

Composition of the Board of Directors

Shareholders: GSK plc

Name	Equities	%	Valuation
BlackRock Fund Advisors 3.075 %	127,119,000	3.075 %	2 421 M p
The Vanguard Group, Inc. 2.735 %	113,090,316	2.735 %	2 154 M p
Dodge & Cox 2.404 %	99,377,874	2.404 %	1 893 M p
Schroder Investment Management Ltd. 1.888 %	78,063,233	1.888 %	1 487 M p
Wellington Management Co. LLP 1.773 %	73,297,902	1.773 %	1 396 M p

Name	Equities	%	Valuation
Dodge & Cox 3.795 %	78,651,833	3.795 %	3 020 M p
Fidelity Management & Research Co. LLC 2.901 %	60,120,517	2.901 %	2 309 M p
Fisher Asset Management LLC 1.449 %	30,031,815	1.449 %	1 153 M p
PRIMECAP Management Co. 1.24 %	25,708,020	1.24 %	987 M p
JTC Employer Solutions Trustee Ltd. 0.7363 %	15,260,368	0.7363 %	586 M p

List of GSK PLC shareholders

Holdings: GSK plc

Name	Equities	%	Valuation
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED 75%	127,054,524	75%	5,017,439,057 $
GLAXOSMITHKLINE PAKISTAN LIMITED 82.59%	263,029,794	82.59%	360,537,569 $
HALEON PAKISTAN LIMITED 85.79%	100,423,259	85.79%	259,409,346 $
WAVE LIFE SCIENCES LTD. 11%	16,775,691	11%	109,041,992 $
CUREVAC N.V. 7.4%	16,591,937	7.4%	90,094,218 $
GLAXOSMITHKLINE S.A.E 91.2%	76,161,378	91.2%	58,562,007 $
VIR BIOTECHNOLOGY, INC. 6.21%	8,550,954	6.21%	43,096,808 $
DONG-A SOCIO HOLDINGS CO., LTD. 6.45%	421,984	6.45%	35,019,418 $
DONG-A ST CO., LTD. 7.87%	736,456	7.87%	25,729,033 $
LYELL IMMUNOPHARMA, INC. 10.22%	1,512,659	10.22%	13,371,906 $

Company details: GSK plc

GSK Plc

79 New Oxford Street

WC1A 1DG, London

+44 20 8047 5000

http://www.gsk.com

Group companies: GSK plc

Name	Category and Sector
GlaxoSmithKline IHC Ltd. GlaxoSmithKline IHC Ltd. Regional BanksFinance Part of GSK Plc, GlaxoSmithKline IHC Ltd. provides banking services. The company is based in Middlesex, UK.	Regional Banks
Glaxosmithkline Investment Services Ltd. Glaxosmithkline Investment Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Glaxosmithkline Investment Services Ltd. provides business support services. The company is based in Middlesex, UK and was founded in 2009.	Miscellaneous Commercial Services
GSK Consumer Healthcare Capital US LLC GSK Consumer Healthcare Capital US LLC Finance/Rental/LeasingFinance Part of Haleon Plc, Haleon US Capital LLC is a company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE.	Finance/Rental/Leasing
GlaxoSmithKline Trading Services Ltd. GlaxoSmithKline Trading Services Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Trading Services Ltd. is an Irish company that manufactures and wholesales pharmaceutical products. The company is based in Dublin, Ireland.	Pharmaceuticals: Major
GlaxoSmithKline Insurance Ltd.

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
GSK PLC	-4.60%	-4.30%	-11.90%	-22.41%	73.24B
ELI LILLY AND COMPANY	+1.34%	-2.69%	-9.09%	+139.83%	693B
JOHNSON & JOHNSON	+0.44%	+4.33%	+5.33%	-6.04%	394B
ABBVIE INC.	-1.12%	-1.66%	+10.59%	+26.54%	334B
NOVO NORDISK A/S	-2.22%	-5.55%	-53.26%	-1.90%	287B
ROCHE HOLDING AG	+0.58%	+0.66%	-7.15%	-21.43%	259B
NOVARTIS AG	-1.12%	-4.09%	-2.94%	+12.40%	223B
ASTRAZENECA PLC	-0.17%	-1.49%	-15.11%	-7.23%	215B
MERCK & CO., INC.	-1.91%	-4.08%	-35.65%	-13.41%	201B
AMGEN INC.	-1.17%	-0.17%	-10.94%	+20.88%	158B
Average	-0.92%	-2.00%	-13.01%	+12.72%	283.82B
Weighted average by Cap.	-0.51%	-1.73%	-11.09%	+34.34%